IL-1 and atherosclerosis: a murine twist to an evolving human story

被引：33
作者：
Rader, Daniel J. [1 ,2 ]
机构：
[1] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Perelman Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA
来源：
JOURNAL OF CLINICAL INVESTIGATION | 2012年 / 122卷 / 01期
关键词：
INTERLEUKIN-1 RECEPTOR ANTAGONIST; NLRP3; INFLAMMASOMES; INFLAMMATION; PATHOGENESIS; CANAKINUMAB; CRYSTALS; DISEASE;
D O I：
10.1172/JCI61163
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Inflammation is a critical component of atherosclerosis. IL-1 is a classic proinflammatory cytokine that has been linked to atherosclerosis. A clinical trial has been launched in which an antibody specific for IL-1 beta is being studied for its effects on cardiovascular events in patients with atherosclerosis. In this issue of the JCI, Alexander et al. report that mice lacking the receptor for IL-1 unexpectedly have features of advanced atherosclerosis that suggest the atherosclerotic plaques may be less stable. These findings illustrate the complexity of inflammatory pathways in atherosclerosis and suggest the need for careful calibration of antiinflammatory approaches to atherosclerosis.
引用
收藏
页码：27 / 30
页数：4
相关论文
共 50 条
  • [31] Differential susceptibility to lethal endotoxaemia in mice deficient in IL-1α, IL-1β or IL-1 receptor type I
    Joosten, Leo A. B.
    van de Veerdonk, Frank L.
    Vonk, Alieke G.
    Boerman, Otto C.
    Keuter, Monique
    Fantuzzi, Giamilla
    Verschueren, Ineke
    van der Poll, Tom
    Dinarello, Charles A.
    Kullberg, Bart Jan
    Van der Meer, Jos W. M.
    Netea, Mihai G.
    APMIS, 2010, 118 (12) : 1000 - 1007
  • [32] IL-1 and IL-1 regulatory pathways in cancer progression and therapy
    Mantovani, Alberto
    Barajon, Isabella
    Garlanda, Cecilia
    IMMUNOLOGICAL REVIEWS, 2018, 281 (01) : 57 - 61
  • [33] Dendritic Cell IL-1α and IL-1β Are Polyubiquitinated and Degraded by the Proteasome
    Ainscough, Joseph S.
    Gerberick, G. Frank
    Zahedi-Nejad, Maryam
    Lopez-Castejon, Gloria
    Brough, David
    Kimber, Ian
    Dearman, Rebecca J.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (51) : 35582 - 35592
  • [34] Expression of IL-1β, IL-1 receptor type I and IL-1 receptor antagonist in human aortic smooth muscle cells:: Effects of all-trans-retinoic acid
    Wagsater, Dick
    Jatta, Ken
    Ocaya, Pauline
    Dimberg, Jan
    Sirsjo, Allan
    JOURNAL OF VASCULAR RESEARCH, 2006, 43 (04) : 377 - 382
  • [35] Inhibition of TNF-α, IL-1α, and IL-1β by Pretreatment of Human Monocyte-Derived Macrophages with Menaquinone-7 and Cell Activation with TLR Agonists In Vitro
    Pan, Min-Hsiung
    Maresz, Katarzyna
    Lee, Pei-Sheng
    Wu, Jia-Ching
    Ho, Chi-Tang
    Popko, Janusz
    Mehta, Dilip S.
    Stohs, Sidney J.
    Badmaev, Vladimir
    JOURNAL OF MEDICINAL FOOD, 2016, 19 (07) : 663 - 669
  • [36] Hepcidin and IL-1β
    Kanamori, Yohei
    Murakami, Masaru
    Sugiyama, Makoto
    Hashimoto, Osamu
    Matsui, Tohru
    Funaba, Masayuki
    IRON METABOLISM: HEPCIDIN, 2019, 110 : 143 - 156
  • [37] Polyphyllin I Mitigated IL-1β-Induced Chondrocytes Damage through Downregulating TWIST1 Expression
    Liu, Feng
    Han, Bowen
    Yang, Deshun
    Ji, Xiaopeng
    Yan, Liangliang
    Han, Chaoyong
    CURRENT MOLECULAR MEDICINE, 2025, 25 (02) : 202 - 210
  • [38] Canakinumab, a fully human mAb against IL-1β for the potential treatment of inflammatory disorders
    Church, Leigh D.
    McDermott, Michael F.
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2009, 11 (01) : 81 - 89
  • [39] IL-1β promotes immunoregulatory responses in human blood basophils
    Iype, Joseena
    Odermatt, Andrea
    Bachmann, Sofia
    Coeudevez, Mazarine
    Fux, Michaela
    ALLERGY, 2021, 76 (07) : 2017 - 2029
  • [40] IL-1 Family Antagonists in Mouse and Human Skin Inflammation
    Martin, Praxedis
    Goldstein, Jeremie D.
    Mermoud, Loic
    Diaz-Barreiro, Alejandro
    Palmer, Gaby
    FRONTIERS IN IMMUNOLOGY, 2021, 12
12345